• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症老年患者在随机临床试验中开始化疗后的结局优先化和偏好。

Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial.

机构信息

Center for Cancer and Aging, City of Hope, Duarte, California, USA.

Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico City, Mexico.

出版信息

Cancer. 2024 Sep 1;130(17):3000-3010. doi: 10.1002/cncr.35333. Epub 2024 Apr 17.

DOI:10.1002/cncr.35333
PMID:38630903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11863993/
Abstract

INTRODUCTION

Older adults with cancer facing competing treatments must prioritize between various outcomes. This study assessed health outcome prioritization among older adults with cancer starting chemotherapy.

METHODS

Secondary analysis of a randomized trial addressing vulnerabilities in older adults with cancer. Patients completed three validated outcome prioritization tools: 1) Health Outcomes Tool: prioritizes outcomes (survival, independence, symptoms) using a visual analog scale; 2) Now vs. Later Tool: rates the importance of quality of life at three times-today versus 1 or 5 years in the future; and 3) Attitude Scale: rates agreement with outcome-related statements. The authors measured the proportion of patients prioritizing various outcomes and evaluated their characteristics.

RESULTS

A total of 219 patients (median [range] age 71 [65-88], 68% with metastatic disease) were included. On the Health Outcomes Tool, 60.7% prioritized survival over other outcomes. Having localized disease was associated with choosing survival as top priority. On the Now vs. Later Tool, 50% gave equal importance to current versus future quality of life. On the Attitude Scale, 53.4% disagreed with the statement "the most important thing to me is living as long as I can, no matter what my quality of life is"; and 82.2% agreed with the statement "it is more important to me to maintain my thinking ability than to live as long as possible".

CONCLUSION

Although survival was the top priority for most participants, some older individuals with cancer prioritize other outcomes, such as cognition and function. Clinicians should elicit patient-defined priorities and include them in decision-making.

摘要

简介

面临多种治疗选择的老年癌症患者必须对各种结果进行优先排序。本研究评估了开始化疗的老年癌症患者的健康结果优先排序情况。

方法

这是一项针对老年癌症患者脆弱性问题的随机试验的二次分析。患者完成了三种经过验证的结果优先排序工具:1)健康结果工具:使用视觉模拟量表对结果(生存、独立性、症状)进行优先排序;2)现在与以后工具:评估患者在三个时间点对生活质量的重视程度,即今天、1 年和 5 年后;3)态度量表:评估患者对与结果相关的陈述的同意程度。作者测量了患者对各种结果进行优先排序的比例,并评估了他们的特征。

结果

共纳入 219 例患者(中位[范围]年龄 71[65-88]岁,68%为转移性疾病)。在健康结果工具上,60.7%的患者将生存作为首要考虑因素。患有局限性疾病的患者更倾向于选择生存作为首要目标。在现在与以后工具上,50%的患者认为当前和未来的生活质量同等重要。在态度量表上,53.4%的患者不同意“对我来说最重要的是尽可能长时间地生存,无论我的生活质量如何”这一说法;82.2%的患者同意“保持我的思维能力对我来说比尽可能长时间地生存更重要”这一说法。

结论

尽管大多数参与者将生存作为首要考虑因素,但一些老年癌症患者会将其他结果(如认知和功能)放在首位。临床医生应该了解患者的优先事项,并将其纳入决策过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74a/11863993/62ae38a23049/nihms-2051300-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74a/11863993/8ebe3d0e8793/nihms-2051300-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74a/11863993/9077cc71a851/nihms-2051300-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74a/11863993/e3e336b393b5/nihms-2051300-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74a/11863993/62ae38a23049/nihms-2051300-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74a/11863993/8ebe3d0e8793/nihms-2051300-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74a/11863993/9077cc71a851/nihms-2051300-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74a/11863993/e3e336b393b5/nihms-2051300-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74a/11863993/62ae38a23049/nihms-2051300-f0004.jpg

相似文献

1
Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial.癌症老年患者在随机临床试验中开始化疗后的结局优先化和偏好。
Cancer. 2024 Sep 1;130(17):3000-3010. doi: 10.1002/cncr.35333. Epub 2024 Apr 17.
2
Understanding health outcome preferences of older adults diagnosed with multiple myeloma.了解诊断为多发性骨髓瘤的老年患者的健康结局偏好。
J Geriatr Oncol. 2024 Jun;15(5):101781. doi: 10.1016/j.jgo.2024.101781. Epub 2024 May 6.
3
Patient-Defined Goals and Preferences Among Adults With Advanced Neuroendocrine Tumors.成人晚期神经内分泌肿瘤患者的目标和偏好。
J Natl Compr Canc Netw. 2022 Dec;20(12):1330-1337.e3. doi: 10.6004/jnccn.2022.7059.
4
Selecting the right treatment: Health outcome priorities in older patients with bladder cancer.选择正确的治疗方法:老年膀胱癌患者的健康结果优先事项。
J Geriatr Oncol. 2024 Jul;15(6):101811. doi: 10.1016/j.jgo.2024.101811. Epub 2024 Jun 18.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Health Outcome Priorities of Older Adults with Advanced CKD and Concordance with Their Nephrology Providers' Perceptions.老年慢性肾脏病 5 期患者的健康结局优先事项及其与肾病学提供者认知的一致性。
J Am Soc Nephrol. 2018 Dec;29(12):2870-2878. doi: 10.1681/ASN.2018060657. Epub 2018 Nov 1.
8
Health outcome priorities in older patients with head and neck cancer.老年头颈部癌症患者的健康结局重点。
J Geriatr Oncol. 2022 Jun;13(5):698-705. doi: 10.1016/j.jgo.2022.02.001. Epub 2022 Feb 24.
9
Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians.癌症患者及其肿瘤临床医生在治疗决策中对生活质量优先事项和偏好的重视。
Cancer. 2020 Aug 1;126(15):3534-3541. doi: 10.1002/cncr.32961. Epub 2020 May 19.
10
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.

引用本文的文献

1
Ethics of overtreatment and undertreatment in older adults with cancer.老年癌症患者过度治疗与治疗不足的伦理学问题
BMC Med Ethics. 2025 Jul 24;26(1):105. doi: 10.1186/s12910-025-01255-9.
2
Unsupervised learning to identify symptom clusters in older adults undergoing chemotherapy.无监督学习用于识别接受化疗的老年人的症状群。
J Geriatr Oncol. 2025 Apr;16(3):102222. doi: 10.1016/j.jgo.2025.102222. Epub 2025 Mar 14.
3
Smartphone application for longitudinal home gait speed measurement in older adults with blood cancers: A feasibility and acceptability study.

本文引用的文献

1
A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020.2017年至2020年期间欧盟用于肿瘤药品监管批准的患者报告结局综述。
Front Med (Lausanne). 2022 Aug 12;9:968272. doi: 10.3389/fmed.2022.968272. eCollection 2022.
2
Patient Preferences for Treatment Outcomes in Oncology with a Focus on the Older Patient-A Systematic Review.肿瘤学中患者对治疗结果的偏好,重点关注老年患者——一项系统综述。
Cancers (Basel). 2022 Feb 23;14(5):1147. doi: 10.3390/cancers14051147.
3
The Time Toxicity of Cancer Treatment.
用于测量老年血癌患者纵向居家步态速度的智能手机应用程序:一项可行性和可接受性研究。
J Geriatr Oncol. 2025 Mar;16(2):102132. doi: 10.1016/j.jgo.2024.102132. Epub 2024 Oct 24.
4
Geriatric assessment for the practicing clinician: The why, what, and how.老年综合评估:临床医生的为何、何为及如何做。
CA Cancer J Clin. 2024 Nov-Dec;74(6):496-518. doi: 10.3322/caac.21864. Epub 2024 Aug 29.
癌症治疗的时间毒性
J Clin Oncol. 2022 May 20;40(15):1611-1615. doi: 10.1200/JCO.21.02810. Epub 2022 Mar 2.
4
Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial.老年综合评估驱动干预(GAIN)对癌症老年患者化疗相关毒性的影响:一项随机临床试验。
JAMA Oncol. 2021 Nov 1;7(11):e214158. doi: 10.1001/jamaoncol.2021.4158. Epub 2021 Nov 18.
5
Decision Making in Older Adults With Cancer.老年癌症患者的决策制定
J Clin Oncol. 2021 Jul 1;39(19):2164-2174. doi: 10.1200/JCO.21.00165. Epub 2021 May 27.
6
How well do healthcare professionals know of the priorities of their older patients regarding treatment outcomes?医护专业人员对老年患者治疗结果的优先事项了解程度如何?
Patient Educ Couns. 2021 Sep;104(9):2358-2363. doi: 10.1016/j.pec.2021.02.044. Epub 2021 Feb 27.
7
Adverse effects of brimonidine eye drop in children: A case series.儿童使用溴莫尼定滴眼液的不良反应:病例系列研究。
J Clin Pharm Ther. 2021 Oct;46(5):1469-1472. doi: 10.1111/jcpt.13401. Epub 2021 Feb 24.
8
Demystifying the estimand framework: a case study using patient-reported outcomes in oncology.揭开估计量框架的神秘面纱:以肿瘤患者报告结局为例的研究。
Lancet Oncol. 2020 Oct;21(10):e488-e494. doi: 10.1016/S1470-2045(20)30319-3.
9
Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program.使用老年综合评估与老年癌症患者沟通:一项来自美国国家癌症研究所社区肿瘤研究计划的集群随机临床试验。
JAMA Oncol. 2020 Feb 1;6(2):196-204. doi: 10.1001/jamaoncol.2019.4728.
10
What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.在转移性乳腺癌的治疗决策中什么是重要的?对患者和肿瘤医生决策的定性分析。
Oncologist. 2019 Oct;24(10):1313-1321. doi: 10.1634/theoncologist.2018-0711. Epub 2019 Mar 14.